Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Wojciak

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2017
Measuring Sphingosine-1-Phosphate/Protein Interactions with the Kinetic Exclusion AssayJonathan K Fleming, Jonathan M Wojciak
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
Arm-site binding by lambda -integrase: solution structure and functional characterization of its amino-terminal domainJonathan M Wojciak, Dibyendu Sarkar, Arthur Landy, et al.
Journal of Molecular Biology|March 12, 2011
Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibodyJonathan K Fleming, Jonathan M Wojciak, Mary-Ann Campbell, et al.
Biochemistry|September 21, 2020
RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1Tadateru Nishikawa, Jonathan M Wojciak, H Jane Dyson, et al.
Journal of Lipid Research|July 23, 2016
A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion AssayJonathan K Fleming, Thomas R Glass, Steve J Lackie, et al.
The EMBO Journal|February 14, 2009
Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domainsJonathan M Wojciak, Maria A Martinez-Yamout, H Jane Dyson, et al.
Journal of Lipid Research|May 17, 2017
High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitisAshlee N King, Jonathan K Fleming, Stephanie S Knapik, et al.
Biochemistry|January 12, 2005
CBP/p300 TAZ1 domain forms a structured scaffold for ligand bindingRoberto N De Guzman, Jonathan M Wojciak, Maria A Martinez-Yamout, et al.
The American Journal of Pathology|July 25, 2018
Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular PathologyWhitney S McDonald, Elizabeth E Jones, Jonathan M Wojciak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2009
The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigenJonathan M Wojciak, Norman Zhu, Karen T Schuerenberg, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Methods in Molecular Biology (Clifton, N.J.)|March 29, 2017
Measuring Sphingosine-1-Phosphate/Protein Interactions with the Kinetic Exclusion AssayJonathan K Fleming, Jonathan M Wojciak
Proceedings of the National Academy of Sciences of the United States of America|March 21, 2002
Arm-site binding by lambda -integrase: solution structure and functional characterization of its amino-terminal domainJonathan M Wojciak, Dibyendu Sarkar, Arthur Landy, et al.
Journal of Molecular Biology|March 12, 2011
Biochemical and structural characterization of lysophosphatidic Acid binding by a humanized monoclonal antibodyJonathan K Fleming, Jonathan M Wojciak, Mary-Ann Campbell, et al.
Biochemistry|September 21, 2020
RNA Binding by the KTS Splice Variants of Wilms' Tumor Suppressor Protein WT1Tadateru Nishikawa, Jonathan M Wojciak, H Jane Dyson, et al.
Journal of Lipid Research|July 23, 2016
A novel approach for measuring sphingosine-1-phosphate and lysophosphatidic acid binding to carrier proteins using monoclonal antibodies and the Kinetic Exclusion AssayJonathan K Fleming, Thomas R Glass, Steve J Lackie, et al.
The EMBO Journal|February 14, 2009
Structural basis for recruitment of CBP/p300 coactivators by STAT1 and STAT2 transactivation domainsJonathan M Wojciak, Maria A Martinez-Yamout, H Jane Dyson, et al.
Journal of Lipid Research|May 17, 2017
High-affinity pan-specific monoclonal antibodies that target cysteinyl leukotrienes and show efficacy in an acute model of colitisAshlee N King, Jonathan K Fleming, Stephanie S Knapik, et al.
Biochemistry|January 12, 2005
CBP/p300 TAZ1 domain forms a structured scaffold for ligand bindingRoberto N De Guzman, Jonathan M Wojciak, Maria A Martinez-Yamout, et al.
The American Journal of Pathology|July 25, 2018
Matrix-Assisted Laser Desorption Ionization Mapping of Lysophosphatidic Acid Changes after Traumatic Brain Injury and the Relationship to Cellular PathologyWhitney S McDonald, Elizabeth E Jones, Jonathan M Wojciak, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 10, 2009
The crystal structure of sphingosine-1-phosphate in complex with a Fab fragment reveals metal bridging of an antibody and its antigenJonathan M Wojciak, Norman Zhu, Karen T Schuerenberg, et al.
Pageof 2